FDA Amends Notice for Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for Deramiocel BLA

Summary

The FDA is updating the meeting details for the Cellular, Tissue, and Gene Therapies Advisory Committee to reflect changes in dates, addresses, and supplementary information, as part of the notice for the Biologics License Application (BLA) 125842 submitted by Capricor, Inc. for Deramiocel, human allogeneic cardiosphere-derived cells.